Tenofovir-associated kidney toxicity in HIV-infected patients: A review of the evidence

American Journal of Kidney Diseases

Volumn 57, Issue 5, 2011, Pages 773-780

  Hall, Andrew M ^a   Hendry, Bruce M ^b   Nitsch, Dorothea ^c   Connolly, John O ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Fanconi syndrome; Kidney; Tenofovir; toxicity

Indexed keywords

AMINOGLYCOSIDE; CREATININE; DIDANOSINE; IFOSFAMIDE; PHOSPHATE; RITONAVIR; TENOFOVIR; VALPROIC ACID;

AGE; BODY WEIGHT; BONE DENSITY; CALCIUM URINE LEVEL; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DNA POLYMORPHISM; DRUG EXCRETION; DRUG POTENTIATION; DRUG TRANSPORT; FANCONI RENOTUBULAR SYNDROME; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPOPHOSPHATEMIA; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE DISORDER; MITOCHONDRIAL TOXICITY; MOLECULAR MECHANICS; NEPHROTOXICITY; NONHUMAN; OSTEOMALACIA; PATIENT MONITORING; PHOSPHATE BLOOD LEVEL; PHOSPHATE EXCRETION; REVIEW; RISK ASSESSMENT;

ADENINE; ANIMALS; FANCONI SYNDROME; GLOMERULAR FILTRATION RATE; HIV INFECTIONS; HUMANS; KIDNEY DISEASES; KIDNEY TUBULES, PROXIMAL; PHOSPHONIC ACIDS; RISK FACTORS;

EID: 79954611097     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.01.022     Document Type: Review

References (63)

1. C.M. Wyatt, and P.E. Klotman Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection Expert Opin Drug Saf 5 2006 275 287 (Pubitemid 43379625)
2. J. Roling, H. Schmid, M. Fischereder, R. Draenert, and F.D. Goebel HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy Clin Infect Dis 42 2006 1488 1495
3. J.E. Gallant, S. Staszewski, and A.L. Pozniak Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial JAMA 292 2004 191 201 (Pubitemid 38917996)
4. J.E. Gallant, E. DeJesus, and J.R. Arribas Tenofovir DF, emtricitabine, and efavirenz vs zidovudine, lamivudine, and efavirenz for HIV N Engl J Med 354 2006 251 260 (Pubitemid 43113030)
5. L.A. Stevens, J. Coresh, T. Greene, and A.S. Levey Assessing kidney functionmeasured and estimated glomerular filtration rate N Engl J Med 354 2006 2473 2483 (Pubitemid 43855050)
6. R.D. Cooper, N. Wiebe, N. Smith, P. Keiser, S. Naicker, and M. Tonelli Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients Clin Infect Dis 51 2010 496 505
7. M.D. Gitman, D. Hirschwerk, C.H. Baskin, and P.C. Singhal Tenofovir-induced kidney injury Expert Opin Drug Saf 6 2007 155 164 (Pubitemid 46380809)
8. M.R. Nelson, C. Katlama, and J.S. Montaner The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years AIDS 21 2007 1273 1281 (Pubitemid 46883481)
9. F.J. de la Prada, A.M. Prados, A. Tugores, M. Uriol, C. Saus, and A. Morey [Acute renal failure and proximal renal tubular dysfunction in a patient with acquired immunodeficiency syndrome treated with tenofovir] Nefrologia 26 2006 626 630
10. A. Malik, P. Abraham, and N. Malik Acute renal failure and Fanconi syndrome in an AIDS patient on tenofovir treatmentcase report and review of literature J Infect 51 2005 E61 E65
11. H. Peyriere, J. Reynes, and I. Rouanet Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases J Acquir Immune Defic Syndr 35 2004 269 273 (Pubitemid 38280652)
12. D. Quimby, and M.O. Brito Fanconi syndrome associated with use of tenofovir in HIV-infected patients: a case report and review of the literature AIDS Read 15 2005 357 364 (Pubitemid 40980486)
13. B.S. Rifkin, and M.A. Perazella Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failure Am J Med 117 2004 282 284 (Pubitemid 39092726)
14. C.L. Woodward, A.M. Hall, and I.G. Williams Tenofovir-associated renal and bone toxicity HIV Med 10 2009 482 487
15. R. Agarwala, S. Mohan, L.C. Herlitz, and J.T. Cheng The case: 41-year-old HIV patient with proteinuria and progressive renal dysfunction Tenofovir toxicity Kidney Int 77 2010 475 476
16. L.C. Herlitz, S. Mohan, M.B. Stokes, J. Radhakrishnan, V.D. D'Agati, and G.S. Markowitz Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities Kidney Int 78 11 2010 1171 1177
17. A.M. Hall, R. Kleta, and R.J. Unwin The renal Fanconi syndrome J. Barrat, K. Harris, P. Topham, Oxford Desk Reference in Nephrology 2009 Oxford University Press New York, NY 204 207
18. A. Karras, M. Lafaurie, and A. Furco Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus Clin Infect Dis 36 2003 1070 1073 (Pubitemid 36513295)
19. F. Rollot, E.M. Nazal, and L. Chauvelot-Moachon Tenofovir-related Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome: the role of lopinavir-ritonavir-didanosine Clin Infect Dis 37 2003 e174 e176
20. J.M. Irizarry-Alvarado, J.P. Dwyer, L.M. Brumble, S. Alvarez, and J.C. Mendez Proximal tubular dysfunction associated with tenofovir and didanosine causing Fanconi syndrome and diabetes insipidus: a report of 3 cases AIDS Read 19 2009 114 121
21. A.M. Bernard, D. Moreau, and R. Lauwerys Comparison of retinol-binding protein and beta 2-microglobulin determination in urine for the early detection of tubular proteinuria Clin Chim Acta 126 1982 1 7 (Pubitemid 13242360)
22. S.L. Day, H.A. Leake Date, A. Bannister, M. Hankins, and M. Fisher Serum hypophosphatemia in tenofovir disoproxil fumarate recipients is multifactorial in origin, questioning the utility of its monitoring in clinical practice J Acquir Immune Defic Syndr 38 2005 301 304 (Pubitemid 40333495)
23. A.M. Hall, S.G. Edwards, and M. Lapsley Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis Am J Kidney Dis 54 6 2009 1034 1042
24. P. Labarga, P. Barreiro, and L. Martin-Carbonero Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir AIDS 23 2009 689 696
25. F.P. Cappuccio, R. Kalaitzidis, S. Duneclift, and J.B. Eastwood Unravelling the links between calcium excretion, salt intake, hypertension, kidney stones and bone metabolism J Nephrol 13 2000 169 177 (Pubitemid 30449492)
26. S.R. Gullans, P.C. Brazy, S.P. Soltoff, V.W. Dennis, and L.J. Mandel Metabolic inhibitors: effects on metabolism and transport in the proximal tubule Am J Physiol 243 1982 F133 F140
27. A. Kabanda, B. Vandercam, A. Bernard, R. Lauwerys, and S.C. van Ypersele de Low molecular weight proteinuria in human immunodeficiency virus-infected patients Am J Kidney Dis 27 1996 803 808 (Pubitemid 26169032)
28. R.F. Miller, M. Shahmonesh, M.G. Hanna, R.J. Unwin, A.H. Schapira, and I.V. Weller Polyphenotypic expression of mitochondrial toxicity caused by nucleoside reverse transcriptase inhibitors Antivir Ther 8 2003 253 257 (Pubitemid 36960901)
29. R.G. Price The role of NAG (N-acetyl-beta-d-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity Clin Nephrol 38 suppl 1 1992 S14 S19
30. M. Horberg, B. Tang, and W. Towner Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients J Acquir Immune Defic Syndr 53 2010 62 69
31. A. Papaleo, J. Warszawski, and R. Salomon Increased beta-2 microglobulinuria in human immunodeficiency virus-1-infected children and adolescents treated with tenofovir Pediatr Infect Dis J 26 2007 949 951 (Pubitemid 47494169)
32. H. Gatanaga, N. Tachikawa, and Y. Kikuchi Urinary beta2-microglobulin as a possible sensitive marker for renal injury caused by tenofovir disoproxil fumarate AIDS Res Hum Retroviruses 22 2006 744 748 (Pubitemid 44735000)
33. E. Kinai, and H. Hanabusa Renal tubular toxicity associated with tenofovir assessed using urine-beta 2 microglobulin, percentage of tubular reabsorption of phosphate and alkaline phosphatase levels AIDS 19 2005 2031 2033 (Pubitemid 41669029)
34. P.G. Davey, and P. Gosling Beta 2-microglobulin instability in pathological urine Clin Chem 28 1982 1330 1333 (Pubitemid 12125066)
35. A.G. Norden, M. Lapsley, and P.J. Lee Glomerular protein sieving and implications for renal failure in Fanconi syndrome Kidney Int 60 2001 1885 1892 (Pubitemid 32999994)
36. C. Kastner, M. Pohl, and M. Sendeski Effects of receptor-mediated endocytosis and tubular protein composition on volume retention in experimental glomerulonephritis Am J Physiol Renal Physiol 296 2009 F902 F911
37. A. Tolaymat, A. Sakarcan, and R. Neiberger Idiopathic Fanconi syndrome in a family Part I. Clinical aspects J Am Soc Nephrol 2 1992 1310 1317
38. T. Cihlar, E.S. Ho, D.C. Lin, and A.S. Mulato Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs Nucleosides Nucleotides Nucleic Acids 20 2001 641 648 (Pubitemid 32821831)
39. T. Imaoka, H. Kusuhara, M. Adachi, J.D. Schuetz, K. Takeuchi, and Y. Sugiyama Functional involvement of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir Mol Pharmacol 71 2007 619 627 (Pubitemid 46147926)
40. M.T. Huisman, J.W. Smit, and K.M. Crommentuyn Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs AIDS 16 2002 2295 2301 (Pubitemid 35449015)
41. A.S. Ray, T. Cihlar, and K.L. Robinson Mechanism of active renal tubular efflux of tenofovir Antimicrob Agents Chemother 50 2006 3297 3304 (Pubitemid 44527501)
42. J.J. Kiser, M.L. Carten, and C.L. Aquilante The effect of lopinavir/ritonavir on the renal clearance of tenofovir in HIV-infected patients Clin Pharmacol Ther 83 2008 265 272
43. S. Rodriguez-Novoa, P. Labarga, and A. D'avolio Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations AIDS 24 2010 1064 1066
44. M. Goicoechea, S. Liu, and B. Best Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy J Infect Dis 197 2008 102 108 (Pubitemid 351263473)
45. J.E. Gallant, and R.D. Moore Renal function with use of a tenofovir-containing initial antiretroviral regimen AIDS 23 2009 1971 1975
46. H. Izzedine, J.S. Hulot, and E. Villard Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy J Infect Dis 194 2006 1481 1491 (Pubitemid 44851889)
47. S. Rodriguez-Novoa, P. Labarga, and V. Soriano Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study Clin Infect Dis 48 2009 e108 e116
48. W. Lewis, and M.C. Dalakas Mitochondrial toxicity of antiviral drugs Nat Med 1 1995 417 422
49. S. Bagnasco, D. Good, R. Balaban, and M. Burg Lactate production in isolated segments of the rat nephron Am J Physiol 248 1985 F522 F526
50. E. Martin-Hernandez, M.T. Garcia-Silva, and J. Vara Renal pathology in children with mitochondrial diseases Pediatr Nephrol 20 2005 1299 1305 (Pubitemid 41226421)
51. P. Niaudet, and A. Rotig The kidney in mitochondrial cytopathies Kidney Int 51 1997 1000 1007 (Pubitemid 27186523)
52. H. Izzedine, V. Launay-Vacher, C. Isnard-Bagnis, and G. Deray Drug-induced Fanconi's syndrome Am J Kidney Dis 41 2003 292 309 (Pubitemid 36152447)
53. A.M. Hall, and R.J. Unwin The not so 'mighty chondrion': emergence of renal diseases due to mitochondrial dysfunction Nephron Physiol 105 2007 1 10
54. G. Birkus, M.J. Hitchcock, and T. Cihlar Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors Antimicrob Agents Chemother 46 2002 716 723 (Pubitemid 34157656)
55. G. Biesecker, S. Karimi, and J. Desjardins Evaluation of mitochondrial DNA content and enzyme levels in tenofovir DF-treated rats, rhesus monkeys and woodchucks Antiviral Res 58 2003 217 225 (Pubitemid 36589012)
56. H.C. Cote, A.B. Magil, and M. Harris Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy Antivir Ther 11 2006 79 86
57. P. Dickie, J. Felser, and M. Eckhaus HIV-associated nephropathy in transgenic mice expressing HIV-1 genes Virology 185 1991 109 119
58. J.J. Kohler, S.H. Hosseini, and A. Hoying-Brandt Tenofovir renal toxicity targets mitochondria of renal proximal tubules Lab Invest 89 2009 513 519
59. D. Lebrecht, A.C. Venhoff, J. Kirschner, T. Wiech, N. Venhoff, and U.A. Walker Mitochondrial tubulopathy in tenofovir disoproxil fumarate-treated rats J Acquir Immune Defic Syndr 51 2009 258 263
60. S. Rodriguez-Novoa, E. Alvarez, P. Labarga, and V. Soriano Renal toxicity associated with tenofovir use Expert Opin Drug Saf 9 2010 545 559
61. A.G. Norden, S.J. Scheinman, and M.M. Schodt-Lanckman Tubular proteinuria defined by a study of Dent's (CLCN5 mutation) and other tubular diseases Kidney Int 57 2000 240 249 (Pubitemid 30227771)
62. S.K. Gupta, J.A. Eustace, and J.A. Winston Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America Clin Infect Dis 40 2005 1559 1585 (Pubitemid 40720806)
63. C.A. Sabin, S.W. Worm, and R. Weber Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration Lancet 371 2008 1417 1426